Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Abstract
Background Anticoagulant treatment for intermittent claudication might improve functional capacity and prevent acute cardiovascular complications caused by peripheral obstructive arterial disease. This is an update of the review first published in 2001. Objectives To assess the effects of anticoagulant drugs (heparin, low molecular weight heparin (LMWH) and oral anticoagulants) in patients with intermittent claudication (Fontaine stage II) in...
Paper Details
Title
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication
Published Date
May 7, 2014
Journal
Volume
2014
Issue
5
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History